Younger adults with atrial fibrillation face higher rates of heart failure and stroke

FHS
April 24, 2024
10:14 am

The risk factor (RF) burden, clinical outcomes, and long-term survival among patients with atrial fibrillation (AF) under 65 years of age.

BI-765179 by Boehringer Ingelheim International for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 6, 2023

Reunion Neuroscience Inc. to Participate in October Investor Conferences – Psychedelic Alpha

WILMINGTON, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions

November 1, 2023

Radiometer and Etiometry announce commercial partnership to empower physicians by optimizing workflows and decision making in high acuity care settings

Radiometer, a leading medical device company specializing in acute care testing solutions, and Etiometry, a leader in clinical decision-support software for critical care, today announced

July 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.